BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
US Department of Justice
Federal Trade Commission
Express Scripts
McKinsey
Accenture
Novartis
AstraZeneca
QuintilesIMS

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020269

« Back to Dashboard

NDA 020269 describes DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%, which is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs. Additional details are available on the DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% profile page.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
Summary for 020269
Tradename:DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Applicant:Hospira
Ingredient:dobutamine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020269

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/100ML
Approval Date:Oct 19, 1993TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/100ML
Approval Date:Oct 19, 1993TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 200MG BASE/100ML
Approval Date:Oct 19, 1993TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Fish and Richardson
Chinese Patent Office
Colorcon
Citi
Merck
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot